LSII

Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries